Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency

Dong Jin Joo, Chul Woo Yang, Hyeon Joo Jeong, Beom Jin Lim, Kyu Ha Huh, Byung Ha Chung, Yeong Jin Choi, Shin-Wook Kang, YuSeun Kim

Research output: Contribution to journalArticle

Abstract

This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion from CNI was performed in patients who underwent kidney transplantation from 6 months to 5 yr prior to screening. Forty-five patients were enrolled. The effect of SRL conversion on graft function was evaluated, and protocol biopsies were performed preconversion and 1 yr after conversion. Overall graft function after SRL conversion gradually improved, and the improvement in renal function was closely associated with the shorter duration of CNI exposure. When we divided the patients by the duration of CNI exposure, the patients with less than 1 yr of CNI exposure demonstrated significant improvement, but patients with a greater than 1 yr CNI exposure did not exhibit significant improvement. In contrast, protocol biopsies demonstrated no significant improvements in the modified "ah" score or other Banff scores after SRL conversion. Furthermore, the duration of CNI treatment prior to SRL conversion was not associated with histological findings 1 yr after SRL conversion. SRL conversion improved graft function in renal recipients with mild to moderate renal insufficiency, but this effect is not accompanied by histological improvement.

Original languageEnglish
Pages (from-to)1069-1076
Number of pages8
JournalJournal of Korean medical science
Volume29
Issue number8
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Sirolimus
Renal Insufficiency
Transplants
Kidney
Biopsy
Calcineurin Inhibitors
Kidney Transplantation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Joo, Dong Jin ; Yang, Chul Woo ; Jeong, Hyeon Joo ; Lim, Beom Jin ; Huh, Kyu Ha ; Chung, Byung Ha ; Choi, Yeong Jin ; Kang, Shin-Wook ; Kim, YuSeun. / Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency. In: Journal of Korean medical science. 2014 ; Vol. 29, No. 8. pp. 1069-1076.
@article{2ca8cf09cfcb479daed01552f7ee4ebe,
title = "Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency",
abstract = "This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion from CNI was performed in patients who underwent kidney transplantation from 6 months to 5 yr prior to screening. Forty-five patients were enrolled. The effect of SRL conversion on graft function was evaluated, and protocol biopsies were performed preconversion and 1 yr after conversion. Overall graft function after SRL conversion gradually improved, and the improvement in renal function was closely associated with the shorter duration of CNI exposure. When we divided the patients by the duration of CNI exposure, the patients with less than 1 yr of CNI exposure demonstrated significant improvement, but patients with a greater than 1 yr CNI exposure did not exhibit significant improvement. In contrast, protocol biopsies demonstrated no significant improvements in the modified {"}ah{"} score or other Banff scores after SRL conversion. Furthermore, the duration of CNI treatment prior to SRL conversion was not associated with histological findings 1 yr after SRL conversion. SRL conversion improved graft function in renal recipients with mild to moderate renal insufficiency, but this effect is not accompanied by histological improvement.",
author = "Joo, {Dong Jin} and Yang, {Chul Woo} and Jeong, {Hyeon Joo} and Lim, {Beom Jin} and Huh, {Kyu Ha} and Chung, {Byung Ha} and Choi, {Yeong Jin} and Shin-Wook Kang and YuSeun Kim",
year = "2014",
month = "1",
day = "1",
doi = "10.3346/jkms.2014.29.8.1069",
language = "English",
volume = "29",
pages = "1069--1076",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "8",

}

Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency. / Joo, Dong Jin; Yang, Chul Woo; Jeong, Hyeon Joo; Lim, Beom Jin; Huh, Kyu Ha; Chung, Byung Ha; Choi, Yeong Jin; Kang, Shin-Wook; Kim, YuSeun.

In: Journal of Korean medical science, Vol. 29, No. 8, 01.01.2014, p. 1069-1076.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sirolimus conversion efficacy for graft function improvement and histopathology in renal recipients with mild to moderate renal insufficiency

AU - Joo, Dong Jin

AU - Yang, Chul Woo

AU - Jeong, Hyeon Joo

AU - Lim, Beom Jin

AU - Huh, Kyu Ha

AU - Chung, Byung Ha

AU - Choi, Yeong Jin

AU - Kang, Shin-Wook

AU - Kim, YuSeun

PY - 2014/1/1

Y1 - 2014/1/1

N2 - This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion from CNI was performed in patients who underwent kidney transplantation from 6 months to 5 yr prior to screening. Forty-five patients were enrolled. The effect of SRL conversion on graft function was evaluated, and protocol biopsies were performed preconversion and 1 yr after conversion. Overall graft function after SRL conversion gradually improved, and the improvement in renal function was closely associated with the shorter duration of CNI exposure. When we divided the patients by the duration of CNI exposure, the patients with less than 1 yr of CNI exposure demonstrated significant improvement, but patients with a greater than 1 yr CNI exposure did not exhibit significant improvement. In contrast, protocol biopsies demonstrated no significant improvements in the modified "ah" score or other Banff scores after SRL conversion. Furthermore, the duration of CNI treatment prior to SRL conversion was not associated with histological findings 1 yr after SRL conversion. SRL conversion improved graft function in renal recipients with mild to moderate renal insufficiency, but this effect is not accompanied by histological improvement.

AB - This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion from CNI was performed in patients who underwent kidney transplantation from 6 months to 5 yr prior to screening. Forty-five patients were enrolled. The effect of SRL conversion on graft function was evaluated, and protocol biopsies were performed preconversion and 1 yr after conversion. Overall graft function after SRL conversion gradually improved, and the improvement in renal function was closely associated with the shorter duration of CNI exposure. When we divided the patients by the duration of CNI exposure, the patients with less than 1 yr of CNI exposure demonstrated significant improvement, but patients with a greater than 1 yr CNI exposure did not exhibit significant improvement. In contrast, protocol biopsies demonstrated no significant improvements in the modified "ah" score or other Banff scores after SRL conversion. Furthermore, the duration of CNI treatment prior to SRL conversion was not associated with histological findings 1 yr after SRL conversion. SRL conversion improved graft function in renal recipients with mild to moderate renal insufficiency, but this effect is not accompanied by histological improvement.

UR - http://www.scopus.com/inward/record.url?scp=84946195463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946195463&partnerID=8YFLogxK

U2 - 10.3346/jkms.2014.29.8.1069

DO - 10.3346/jkms.2014.29.8.1069

M3 - Article

C2 - 25120315

AN - SCOPUS:84946195463

VL - 29

SP - 1069

EP - 1076

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 8

ER -